Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of GSK GlaxoSmithKline PLC | 19.3% in 12m

Compare GSK with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare GlaxoSmithKline PLC with its related Sector/Index XLV

Compare GlaxoSmithKline PLC with its related Sector/Index XLV

Performance Duell GSK vs XLV

TimeFrame GSK XLV
1 Day 0.76% 0.03%
1 Week 3.38% 0.73%
1 Month -2.64% -3.99%
3 Months 8.59% 0.86%
6 Months 14.4% 12.64%
12 Months 19.3% 8.01%
YTD 12.8% 1.21%
Rel. Perf. 1m 0.11
Rel. Perf. 3m 0.79
Rel. Perf. 6m 0.37
Rel. Perf. 12m 0.81

Is GlaxoSmithKline PLC a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, GlaxoSmithKline PLC (LSE:GSK) is currently (April 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSK as of April 2024 is 1576.54. This means that GSK is currently overvalued and has a potential downside of -4.63% (Sold with Premium).

Is GSK a buy, sell or hold?

GlaxoSmithKline PLC has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 19.27%.

In compare to Health Care Sector SPDR Fund, GSK made 11.26% more over the last 12 months. Due to the outperformance, it is recommend to buy GSK.
Values above 0%: GSK is performing better - Values below 0%: GSK is underperforming

Compare GSK with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.73% -0.61% -9.73% -8.25%
US NASDAQ 100 QQQ -0.56% 0.14% -11.55% -19.85%
US Dow Jones Industrial 30 DIA 2.72% -0.01% -3.36% 2.22%
German DAX 40 DBXD 1.04% -1.29% -8.69% 5.00%
UK FTSE 100 ISFU -0.13% -4.19% -1.38% 11.76%
Shanghai Shenzhen CSI 300 CSI 300 2.47% -3.96% 11.87% 31.06%
Hongkong Hang Seng HSI -5.33% -4.62% 16.06% 37.74%
Japan Nikkei 225 EXX7 3.45% 5.37% -2.73% 1.48%
India NIFTY 50 INDA 1.45% -5.71% -8.09% -10.93%
Brasil Bovespa EWZ 0.78% -0.41% 7.24% -2.69%

GSK GlaxoSmithKline PLC vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 2.57% -1.09% -12.82% -24.78%
Consumer Discretionary XLY -0.24% 0.89% -4.95% -4.11%
Consumer Staples XLP 1.84% -2.80% 0.68% 17.14%
Energy XLE 2.57% -6.10% 1.97% 0.69%
Financial XLF 2.29% -1.24% -14.20% -9.52%
Health Care XLV 2.65% 1.35% 1.71% 11.26%
Industrial XLI 1.56% -1.60% -12.80% -9.15%
Materials XLB 2.75% -0.66% -6.31% 2.96%
Real Estate XLRE 1.76% 2.19% 1.49% 15.65%
Technology XLK -0.41% 1.13% -10.88% -18.61%
Utilities XLU 2.22% -6.99% 1.81% 18.97%
Aerospace & Defense XAR 0.45% -0.89% -5.45% -2.72%
Biotech XBI 2.58% 7.29% -11.83% 14.03%
Homebuilder XHB -0.17% 2.49% -34.42% -35.47%
Retail XRT 0.50% 2.07% -11.43% -3.10%

GSK GlaxoSmithKline PLC vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 1.43% -6.65% 9.80% -3.73%
Natural Gas UNG 6.55% 3.38% 66.27% 67.27%
Gold GLD 5.38% -10.07% -3.37% 2.01%
Silver SLV 8.38% -14.05% -5.03% 10.25%
Copper CPER 1.78% -16.75% -13.28% -1.65%

Returns of GSK vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 4.40% 2.94% 8.15% 32.80%
iShares High Yield Corp. Bond HYG 2.54% -2.03% 5.31% 10.51%
Does GlaxoSmithKline PLC outperform its market, is GSK a Sector Leader?
Yes, over the last 12 months GlaxoSmithKline PLC (GSK) made 19.27%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.01%.
Over the last 3 months GSK made 8.59%, while XLV made 0.86%.
Period GSK XLV S&P 500
1 Month -2.64% -3.99% -2.03%
3 Months 8.59% 0.86% 4.60%
12 Months 19.27% 8.01% 27.52%